Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionSemaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
This study evaluates the effectiveness and safety of semaglutide and tirzepatide in patients with cardiometabolic heart failure with preserved ejection fraction in clinical practice. This study evaluates the effectiveness and safety of semaglutide and tirzepatide in patients with cardiometabolic heart failure with preserved ejection fraction in clinical practice.
New Molecules and Indications for GLP-1 MedicinesNew Molecules and Indications for GLP-1 Medicines
This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines. This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.
Social Adversity and Triple-Negative Breast Cancer Incidence Among Black WomenSocial Adversity and Triple-Negative Breast Cancer Incidence Among Black Women
This cohort study investigates the association between social adversity and incidence of triple-negative breast cancer among US Black women.
How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?
(MedPage Today) — Three GLP-1 receptor agonists had generally comparable cardiorenal outcomes when used in type 2 diabetes, a retrospective comparative effectiveness study indicated. Among 21,790 military veterans with diabetes, initiators of… (MedPage Today) — Three GLP-1 receptor agonists had generally comparable cardiorenal outcomes when used in type 2 diabetes, a retrospective comparative effectiveness Read More
Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 DiabetesLiraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes
This comparative effectiveness study examines risks of kidney, cardiovascular, and death outcomes among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the Veterans Health Administration. This comparative effectiveness study examines risks of kidney, cardiovascular, and death outcomes among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the Veterans Health Read More
Breast Cancer Incidence Rates in Ghanaian and US Black Women, 2013-2015Breast Cancer Incidence Rates in Ghanaian and US Black Women, 2013-2015
This cross-sectional study investigates age-standardized incidence rates of estrogen receptor–negative and estrogen receptor–positive breast tumors among Ghanaian women and US non-Hispanic Black and non-Hispanic White women with breast cancer.
This Breast Cancer Ribbon Has a Different Take on Pink. Here’s What It MeansThis Breast Cancer Ribbon Has a Different Take on Pink. Here’s What It Means
Landmarks around the world will light up in its colors for Breast Cancer Awareness Month.
Hallmark star says Stage 3 breast cancer diagnosis has spiritually ‘stripped’ her downHallmark star says Stage 3 breast cancer diagnosis has spiritually ‘stripped’ her down
Crystal Lowe detailed the harrowing moment she learned about her cancer diagnosis and explained how it has spiritually and physically “stripped” her down.
ACS Study Finds Worsening Survival Disparities by Health Insurance and Race Among Women With Breast CancerACS Study Finds Worsening Survival Disparities by Health Insurance and Race Among Women With Breast Cancer
Post Content Post Content
Living near toxic Superfund sites linked to aggressive breast cancerLiving near toxic Superfund sites linked to aggressive breast cancer
Breast cancer is the second leading cause of cancer death among women, according to the American Cancer Society. Now, three recent studies by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have uncovered links between breast cancer, Superfund sites and social adversity.